Abstract
Vascular endothelial growth factor-C (VEGF-C) is a secreted growth factor essential for lymphangiogenesis. VEGF-C functions in both physiological and pathological lymphangiogenesis, particularly in tumor metastasis, making it an attractive therapeutic target. Members of two families of cell surface receptors transduce VEGF-C signals: neuropilin-2 (Nrp2) and VEGF-receptor (VEGFR)-2/3. Nrp2 is a promising target for inhibition because it is highly expressed in lymphatic vessels. Here we describe a microplate-based assay for discovery of VEGF-C/Nrp2 inhibitors. We optimize this assay for use in screening an inhibitor library and identify three novel Nrp2/VEGF-C binding inhibitors from the National Institutes of Health (NIH) Clinical Collection small molecule library.
Original language | English |
---|---|
Pages (from-to) | 4-6 |
Number of pages | 3 |
Journal | Analytical Biochemistry |
Volume | 453 |
Issue number | 1 |
DOIs | |
State | Published - May 15 2014 |
Bibliographical note
Funding Information:This work was supported by National Institutes of Health (NIH) grants R01GM094155 (C.W.V.K.) and T32HL072743 (M.W.P.).
Funding
This work was supported by National Institutes of Health (NIH) grants R01GM094155 (C.W.V.K.) and T32HL072743 (M.W.P.).
Funders | Funder number |
---|---|
National Institutes of Health (NIH) | R01GM094155 |
National Heart, Lung, and Blood Institute (NHLBI) | T32HL072743 |
Keywords
- Assay
- Inhibitor
- Ligand
- Neuropilin
- Receptor
- VEGF
ASJC Scopus subject areas
- Biophysics
- Biochemistry
- Molecular Biology
- Cell Biology